MedTrace Logo

T1DM Clinical Onset and Progression in Paediatric Population

NCT03547440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2024-12-04

No results posted yet for this study

Summary

Diabetes Mellitus Type I is the chronic metabolic disease of childhood with the highest incidence in developed countries. Over the past 10 years the incidence of diabetes has been increased especially in immigrants children. The objective of the investigator's project is to evaluate factors that influence the T1DM course in immigrant and Italian children through an analysis of the relationship between socio-cultural determinants, lifestyles and metabolic control. The study population will consist of 100 children with first diagnosis of T1DM divided into two cohorts (Italian and immigrant children). The project consists in a follow-up of 18 months from first visit and will include laboratory tests, two questionnaires and determination of a microbiological indicator of the microbiota and levels of 25-hydroxyvitamin D. The research hypothesis is that the two groups of study population show a different metabolic control of diabetes due to differences in access to care, compliance to therapy and type of nutrition.

Conditions

  • Type 1 Diabetes Mellitus

Sponsors & Collaborators

  • Azienda Ospedaliero Universitaria Maggiore della Carita

    collaborator OTHER

  • A.O.U. Città della Salute e della Scienza

    collaborator OTHER

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Roberta T Siliquini, Prof. · University of Turin - Hygiene and Preventive Medicine

Eligibility

Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-18
Primary Completion
2017-06-30
Completion
2018-09-18

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547440 on ClinicalTrials.gov